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ABSTRACT: A former spectroscopic study of Cu(II)
coordination by the 13-membered ring cyclic tetrapeptide
c(Lys-DHis-βAla-His) (DK13), revealed the presence, at
alkaline pH, of a stable peptide/Cu(III) complex formed in
solution by atmospheric dioxygen oxidation. To understand
the nature of this coordination compound and to investigate
the role of the His residues in the Cu(III) species formation,
Cu K-edge XANES, and EXAFS spectra have been collected
for DK13 and two other 13-membered cyclo-peptides: the
diastereoisomer c(Lys-His-βAla-His) (LK13), and c(Gly-βAla-
Gly-Lys) (GK13), devoid of His residues. Comparison of pre-
edge peak features with those of Cu model compounds,
allowed us to get information on copper oxidation state in two
of the three peptides, DK13 and GK13: DK13 contains only
Cu(III) ions in the experimental conditions, while GK13 binds
only with Cu(II). For LK13/Cu complex, EXAFS spectrum
suggested and UV−vis analysis confirmed the presence of a
mixture of Cu(II) and Cu(III) coordinated species. Theoreti-
cal XANES spectra have been calculated by means of the
MXAN code. The good agreement between theoretical and
experimental XANES data collected for DK13, suggests that
the refined structure, at least in the first coordination shell
around Cu, is a good approximation of the DK13/Cu(III)
coordination species present at strongly alkaline pH. All the
data are consistent with a slightly distorted pyramidal CuN4
unit, coming from the peptide bonds. Surprisingly, the His
side-chains seemed not involved in the final, stable, Cu(III)
scaffold.
■ INTRODUCTION
The study of the behavior of acyclic and cyclic peptides is
growing in importance because of the actions that many of
these substances display, working like hormones, antibiotics,
enzymes or metals carrier molecules. In addition, the
coordination geometry of metal ions in peptides is of great
interest, mimicking the complexation sites in macromolecular
ligands like proteins. Among the metallic oligo-elements
necessary to the human life, the copper, even not the most
abundant one, is however one the most active in the
biochemical pattern, and it is deeply involved in the mechanism
of the cellular redox reactions. Copper ions, in fact, are found in
the active pocket of a versatile group of redox catalysts like
citocrome-c oxidase, galactose oxidase, or superoxide dismutase
(SOD) and play a fundamental role in the cell protection from
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ROS dangerous activity. Moreover, Cu(II) ion is the most
tightly bound metal ion in the chelating centers of biological
molecules, which accounts for the fact that the copper present
in living cells is almost entirely coordinated by peptides or
proteins. Notably, copper(II) is stored at high levels in the
brain cells through the human prion protein (PrP), where it is
bonded to four repeats of the eight-residue sequence
PHGGGWGQ by one imidazole and two amide nitrogens, at
neutral pH value.1 A correct homeostasis of copper is therefore
essential for the right physicochemical equilibrium of the
organism: the required amount of copper(II) ion assumed by
the diet lies in the range of 1.5−3.0 mg pro die. The control of
toxicity of copper is based on mechanisms related to redox
enzymes function, extra- and intracellular chelation and a fine-
tuning of the transmembrane transport. Hence, the effective
plasma transport of copper is also fundamental for the
homeostasis of this metal and it is ensured by various proteins
like ceruloplasmin and serum albumin. Noteworthy, a
significant fraction of Cu(II) is also bonded to low-weight
peptide species which act as carriers in the biological fluids.2 In
His containing peptides and proteins, at the physiological pH
values, Cu(II) is tightly bonded to the imidazole side-chain of
the His residues, which are able to coordinate copper ions since
acidic pH. Peptide bonds could be also deprotonated already at
pH 7 by Cu(II) coordination, often with the simultaneous
involvement of the N-3 imidazole atom to form penta- or
hexaatomic-cycles.1 Moreover, cyclopeptides of suitable size are
generally prone to coordinate Cu(II) stronger than the parent
linear oligopeptides. That is true when cyclotetrapeptides with
the −His-Xaa-His− motif are implicated in the coordination.3
This prompted us to undertake a systematic study on the
speciation of Cu(II) complexes in several oligopeptides
containing histidine residues, especially cyclic peptides of
different cavity size.4−9 The coordination of Cu(II) ion with
these molecules was studied in a large range of pH values by
potentiometric and spectroscopic methods. This allowed us to
detect the principal donor sets and to determine the structure
of the most abundant species in equilibrium. In all the studied
peptides, linear and cyclic as well, we were dealing with
peptide/copper(II) complexes. In particular, c(Lys-DHis-Gly-
His) and c(β3homoLys-DHis-βAla-His), containing 12- and 14-
atoms rings, respectively, gave well-defined CuH−4L species at
strong alkaline pH, with 4N equatorial donor set around Cu(II)
coordination and the involvement of the Im nitrogens,
affording octahedral-like structures.
Recently, we prepared a new 13-member cyclotetrapeptide,
containing the DHis-Xaa-LHis motif c(Lys-DHis-βAla-His)
(DK13), (1). Surprisingly, preliminary studies carried out by
optical spectroscopy, NMR, MS, and electrochemistry methods,
suggested that, in strongly alkaline aqueous solutions, the added
Cu(II) was almost completely transformed in Cu(III) species
through the action of dioxygen dissolved in the solution.10
Notably, the ligand c(Gly-βAla-Gly-Lys) (GK13) (3) contain-
ing a cycle of the same size but devoid of His residues, appeared
to bond only Cu(II) ions in the same conditions by UV−vis
inspection. We noticed also that the stabilization effect obtained
by peptide (1) on the potent oxidizing agent Cu(III) is by far
strongest than that reported for the related Cu(III) complex
with the 14-membered peptide c(βAla-Gly-βAla-Gly).11
Attempts to clarify the DK13/Cu(III) complex structure by
means of usual X-ray diffraction analysis on powdered samples
failed. This prompted us to use the more powerful synchrotron
radiation method for investigating the nature of the copper
complexes of this cyclopeptide. In the following, we report an
enhanced Cu K-edge XANES and EXAFS structural study of
the DK13/Cu(III) complex, carried out at the ESRF facility of
Grenoble on solid state samples obtained by liophylisation of
strong alkaline solutions. Similarly, X-rays data for mixtures of
Cu(II) with the diastereoisomer peptide c(Lys-His-βAla-His)
(LK13) (2) and with GK13 (3) were collected at ESRF and the
results compared with those obtained for DK13.
■ EXPERIMENTAL SECTION AND DATA REDUCTION
Synthesis of the Cyclopeptides. Chloro-trityl resin
(100−200 mesh) was from Novabiochem AG (Laufelfingen,
Switzerland). All aminoacids, TBTU and HOBt are from Iris
Biotech (Marktredwitz, Germany), HATU from ChemPep
(Wellington, USA). Peptide-synthesis grade DMF was from
Scharlau (Barcelona, Spain). HPLC-grade MeCN was
purchased from Carlo Erba (Italy). Dry solvents were distilled
immediately before use. All other chemicals were commercial
compounds and were used as received. The solid-phase
syntheses were performed on semiautomatic synthesizer
(MultiSynTech − Germany). 1H NMR spectra were recorded
on a Varian Gemini 300 MHz or Varian Inova 400 MHz
spectrometer in DMSO-d6 or D2O. Chemical shifts are
reported in ppm (δ) downfield from tetramethylsilane.
Electrospray ionization mass spectra (ESI-MS) were acquired
on LCQ-Advantage ESI ion trap spectrometer (Thermo
Finnigan) for positive and negative ions detection. The purity
Chart 1. Three Cyclopeptides Studied
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of the final compounds was checked by HPLC and by
combustion analysis, performed on a Perkin-Elmer 240 C
elemental analyzer.
The syntheses of DK13 (1) and GK13 (3) have been
previously reported.10 Briefly, linear tetrapeptide precursor of
DK13 was prepared following the SPPS method and using the
orthogonal Fmoc/Trt/allyl protection scheme on a trityl type
resin, by anchoring the imidazole side-chain. The chain
elongation was achieved according to SPPS standard protocol,
and the on-resin cyclic compound was obtained in the
pseudodilution conditions, forming the peptide bridge by
TBTU/DIPEA method in DMF. The cyclization yield was
>90%, without the presence of oligomer byproducts. The
synthesis and cyclization were performed as reported for DK13.
Peptides cleavage from the resin and deprotection of the
aminoacids side chains were carried out with TFA/H2O/TIS
(95:2.5:2.5) while the crude cyclic compounds were both
purified by RPC18−HPLC and characterized by LC-ESI-MS.
The solvent systems used for gradients were A (0.1% TFA in
H2O) and B (0.1% TFA in CH3CN).
Synthesis of (3S,6S,9S)-3,9-Bis((1H-imidazol-4-yl)-
methyl)-6-(4-aminobutyl)-1,4,7,10-tetraazacyclotride-
cane-2,5,8,11-tetraone (LK13) (2). The synthesis started
from Fmoc-His(trityl-resin)-OAl (500 mg, 0.46 mmol/g).
Fmoc deprotection was performed by 20% piperidine in
DMF (2 × 5 mL) for 15 min. Amino acids residues (β-Ala; His
and Lys, respectively) were then introduced according to the
TBTU/HOBt/NMM method for the active esters formation.
The coupling reactions were performed by using excess of the
amino acids, HOBt and TBTU (4 equiv) and of NMM (8
equiv) in DMF, under vortex mixing for 40 min. After
deprotection, the cyclization was performed as reported for
compound 1. The crude LK13 was prepurified by solid phase
extraction (SPE) and semipreparative RP-HPLC (0% to 20% of
B in 30 min.) giving 2 (65 mg, 16% overall yield). Analytical
HPLC (3% to 20% of B in 5 min.; flow 600 μL/min): tR = 1.47
min; ESI-MS: m/z calcd [M+H]+, 474.53, found 474.42.
Elemental analysis. Found: C, 39.09; H, 4.46; N, 15.21%.
Calculated for C21H31N9O4·1H2O·3TFA: C, 38.90; H, 4.35; N,
15.12%. The preparations of the copper−peptide complexes for
XANES and EXAFS experiments are described in Supporting
Information.
Spectroscopic Investigations. UV−vis spectroscopy data
have been acquired with a Varian Cary 50 instrument, using a
mixture of cyclopeptides 1, 2, and 3, respectively (0.15 mM)
and 0.1 mM Cu(II), in air saturated aqueous solutions, at pH
12.2, in the range from 200 to 800 nm.
X-ray absorption spectroscopy (XAS) data have been
collected at the ID26 beamline of the ESRF storage ring
(Grenoble, F) with ring current ranging from 90 to 60 mA, on
solid samples obtained by liophylisation of freshly prepared
aqueous solutions (cyclopeptide/copper 1:0.9) at high pH
values. Radiation was monochromatised by means of a double-
crystal Si (311) monochromator to achieve high-energy
resolution at the Cu K-edge. Beam size at the sample was
250 × 1000 μm. Cu K-edge XANES and EXAFS spectra were
acquired in fluorescence mode monitoring the emitted
fluorescence signal with a high-purity multielement Ge
detector. XAS data were collected in quick-scan mode by
simultaneously scanning the monochromator angle and the
undulator gap with a typical energy step of 0.2 eV and counting
about 160 ms per point. In order to reduce radiation induced
damage of the peptide samples, spectra have been collected at
10 K in a He cryostat, and the intensity of the incident radiation
at the sample has been adjusted by means of Al filters.
Preliminary time scans allowed to ascertain that the samples
suffered no damage within 1300 s exposure to the X-ray beam.
For each sample 1000 s long spectra have been acquired at
different sample positions in order not to alter the sample.
Average of 10 to 60 scans, depending on sample Cu
Figure 1. XANES spectra of Cu model compounds with known oxidation state (left panel) and the peptides under study (right panel).
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concentration, allowed to obtain a good signal-to-noise ratio for
all the samples.
Experimental XANES spectra were corrected by background
subtraction with a linear function and then normalized for
atomic absorption on the average absorption coefficient of the
spectral region from 9030 to 9210 eV. Energy was calibrated
against a standard of Cu metal (8979 eV). The threshold
energy was taken as the first maximum of the first derivative of
the spectra, whereas peak positions were obtained by
calculating the second derivative of the spectra. Pre-edge peak
analysis was carried out following the same procedure found in
Wilke et al.12 The pre-edge peak was fitted by a sum of pseudo-
Voigt function, and the integrated intensities along with
centroid energies were compared with those of the standards
analyzed here and others from the literature in order to extract
information on Cu oxidation state and coordination number in
the samples studied.
EXAFS data reduction and analysis was done by means of the
GNXAS package (Filipponi & Di Cicco, 2000).13 This program
extracts χ(k) signal from the raw spectrum without performing
Fourier filtering and thus avoiding possible biases deriving from
incorrect background subtraction. The theoretical amplitudes
and phase shifts are calculated ab initio according to the Muffin-
Tin approximation. The Hedin−Lundqvist complex potential14
was used for the exchange-correlation potential of the excited
state. The amplitude reduction factor (S0
2) has been fixed to
0.85.
XANES analysis has been carried out by using the MXAN
program15 working in the frame of the one-electron, multiple
scattering theory using a complex, “Muffin-Tin” molecular
potential.16 The real part of the exchange term of the potential
was calculated using the Hedin−Lundqvist energy-dependent
potential16 while the imaginary part of the potential, taking into
account all of the inelastic losses, was mimicked by a
phenomenological method previously described in detail.16,17
Starting atomic coordinates were first calculated according to a
DFT minimization; the XANES spectrum was then calculated
using the real Hedin−Lundqvist potential convoluted with a
broadening function, with a width Γ given by Γ = Γc + Γ(E).
The constant part Γc includes contributions from the core-hole
lifetime (1.5 eV, Lorentzian convolution) and the experimental
resolution (0.6−0.8 eV, Gaussian convolution), while the
energy dependent term Γ(E) (Lorentzian convolution)
represents the inelastic processes. Γ(E) follows the universal
functional form related to the mean free path in a solid,18 but it
is also refined during the procedure. Structural optimization
was performed by minimizing the χ2 function of the theoretical
vs experimental fit in the space of two structural parameters,
that is, the first (4 nitrogens) and second (8 carbons)
coordination shell.
■ RESULTS AND DISCUSSION
Pre-edge Analysis. In Figure 1 are shown the XANES
spectra of representative Cu model compounds with known
oxidation state and the peptides under study. As the metal K-
edge structures vary according to number, type, and geometric
arrangements of ligands, as well as the metal oxidation state,
comparison of the peptide spectra with those of model
compounds can allow to get information on the oxidation
state and structural surrounding of the studied metal (i.e., Cu).
It is apparent a general shift to higher energy of the
absorption threshold of the model compound spectra with
increasing Cu oxidation state from Cu(I) to Cu(III). Also a
peak labeled A in the edge region shifts to higher energy with
increasing Cu oxidation state. Moreover, a peak in the pre-edge
region (peak P) is absent in the Cu(I) model compounds
whereas is present in Cu(II) and Cu(III) compounds. This
peak, often referred as pre-edge peak, is related to a 1s to 3d
electronic transition in the photoabsorbing atom (in this case
Cu) and is a direct probe of the unfilled d orbital
population.19,20 The observed variations of edge positions
and pre-edge peak position and intensities have been already
observed in a number of systems of both organic and inorganic
nature.21−24 However, the quantitative interpretation of
XANES spectra is sometimes rendered difficult because of
the complexity of multiple scattering paths involved and
Figure 2. UV−vis spectral trend for DK13/Cu (red line), LK13/Cu (black line) and GK13/Cu (blue line) in acqueous solutions at pH 12.2.
Peptides concentration 0.15 × 10−3 M; ligand to metal ratio 1:0.9. In the inset are reported the d−d transitions because of the presence of Cu(II) in
LK13 (black line), GK13 (blue line), and c(β3homoAsp-DHis-βAla-His) (green line) complexes. Peptides concentration = 1.5 × 10−3 M; ligand to
metal ratio = 1:0.9.
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because of the high number of factors affecting the shape of the
XANES region. In this respect, the pre-edge peak can be solely
an indication of the metal oxidation state.25 The background
subtracted pre-edge peak is shown in the inset of Figure 1 for
both the model compounds (left panel) and peptides (right
panel). The energy position of this peak can be a precise
indication of the Cu oxidation state: while it is absent in Cu(I)
compounds, it is present at ca. 8978 eV for most Cu(II) model
compounds. Its shift to higher energy and increase in integrated
intensity in the case of Cu(III) compounds. The Cu(III) model
compound shown here [ditellurate cuprate(III), DTC] display
a pre-edge peak centroid at 8979.3 ± 0.3 eV with an integrated
intensity of 0.044. Comparison of peptide pre-edge peak data
with those of model compounds can probe Cu oxidation state
in the studied peptide samples. Accurate analysis of pre-edge
peak data of the peptide samples allowed to ascertain the
presence of Cu(III) in cyclopeptide 1 and of Cu(II) in
cyclopeptide 3 samples, respectively. In particular, while the
pre-edge peak of the GK13/Cu sample is perfectly compatible
with those of divalent Cu model compounds analyzed here and
reported in the literature, the pre-edge peak of DK13 spectrum
display an energy (8979.8 eV) compatible to that of the DTC
shown here (and with other data from the literature22) but has
an higher integrated intensity (0.095) than the DTC, possibly
due to a less centrosymmetric geometrical environment around
Cu than in the DTC. The small increase in the pre-edge
intensity in LK13/Cu sample (2) could indicate a small amount
of Cu(III), or could merely be due to change in site symmetry.
To clarify wich of the two hypotheses was correct, we
investigated the presence of a Cu(III) complex in LK13/Cu
by means of the UV−vis spectroscopy.
UV−vis Analysis. The comparison of UV−vis spectra of
the three peptide/copper complexes, reported in Figure 2,
strongly supports the XANES data. The DK13/copper
spectrum shows two strong absorptions at λmax 252 and 332
nm which can be attributed to LMCT bands diagnostic for
Cu(III)/peptide square planar complexes.10,26 (Table1). The
very weak and broadened absorbance at ∼510 nm cannot be
attributed to a Cu(III) CT (the ε ≅ 380 would be low) and
suggests the presence of a residual Cu(II) complex. On the
contrary, the spectral pattern of compound (3)/Cu(II) solution
does not show anywhere the characteristic maxima at ∼250 and
∼330 nm but only a broad absorption at about 520 nm whose
low molar absorptivity (101 M−1 cm−1) is in agreement with a
d-d transition of a coordinated Cu(II) ion, probably due to
peptide 4N− donor set like the smaller c(HGHK) (λmax 529
nm, pH 12.8).8 Conversely, the LK13/Cu spectral pattern
shows a shoulder at about 250 nm and a maximum just at 332
nm, well in accordance with the occurrence of the peptide/
Cu(III) species. The simultaneous presence of the broad
absorption at ∼470 nm, assignable to the d-d transition of a
Cu(II) coordinated species,9 confirms the largely incomplete
oxidation of Cu(II) ions. For the sake of clarity, the inset of
Figure 2 reports also the UV−vis spectrum of the
c(β3homoAsp-DHis-βAla-His)/Cu(II) complex at pH 11 (λmax
474 nm, unpublished data). Quantitative analysis of Cu(III)/
Cu(II) ratios cannot be reasonably carried out at this stage but
qualitative results seem in good agreement with the pre-edge
analysis obtained by XANES.
EXAFS Analysis. In Figure 3 are shown the experimental
(open symbols), theoretical (solid lines), and residual EXAFS
signals of the DK13/Cu(III) and GK13/Cu(II) samples. The
theoretical signals have been calculated starting from a
simplified model structure reproducing the 13-element ring
and neglecting the imidazole side chains contributions. The
signals have a low intensity and are almost completely dumped
in the high-energy region. The Fourier transforms of the
EXAFS signals confirm that there are no important
contributions from distances farther than 4 Å.
The theoretical contributions to the EXAFS signals from
each shell of the model structure are shown in Figure 4 for two
peptides: The most important contributions comes from the 4
N atoms bonded to Cu and from the 6 nearest C atoms. The
other three contributions refer to longer Cu−C distances
within 4.0 Å from the Cu site. The EXAFS derived Cu−N
distances are sensibly shorter in the DK13/Cu sample relative
to GK13/Cu (1.78 ± 0.02 Å and 1.91 ± 0.02 Å respectively).
The shorter distance (1.78 Å for DK13) is consistent with
other Cu(III)-N distances found in the literature22 and is thus a
further confirmation of the presence of trivalent copper in this
peptide. On the other hand, the Cu−N distance found for
GK13/Cu (1.91 Å) compares well with known values for
divalent copper.22,27
XANES Analysis. Theoretical XANES spectra of DK13 and
GK13 copper complexes are shown in Figure 5, left frame.
Whereas, as expected, prepeak P cannot be reproduced, the
main features A, B, C, D of the edge, and their changes going
from GK13/Cu to DK13/Cu are satisfactorily reproduced in
the one-electron, multiple scattering scheme adopted by the
MXAN program. In particular the observed blue-shift of the
spectrum going from the cuprous to cuprate compound
correspond to a decrease of the average first shell distance. In
the right frame, the Theoretical vs Experimental fit concerning
DK13 and GK13 copper complexes, is displayed.
In this figure, the experimental spectra have been shifted by
∼8985 eV to lower energy to match the theoretical spectra. The
fits include the first and second shell average distances. Electron
damping and all the anelastic losses are taken into account by a
phenomenological broadening function (see the Supporting
Information). Because of the poor approximation used for this
function, the details of the edge features (at 0−20 eV) are
smeared out in the theoretical spectra, however they are
unessential for the fit results that are based on the simulation of
a much longer energy range. The results of the MXAN fits are
in quite agreement with the EXAFS analysis (see Table 2). The
Cu−N average distance is 1.80 ± 0.04 Å for DK13 and 1.91 ±
0.02 Å for GK13, while the average second shell Cu−C distance
(calculated on the eight nearest carbon atoms) is 2.84 ± 0.08
and 2.94 ± 0.02 Å, respectively.
Table 1. Spectroscopic Data for the Three Peptide/Cu
Complexes at 20 °Ca
peptide/Cu complex λmax (nm) ε (cm
−1 M−1)
DK13 254b 9570
332b 5823
∼510c
LK13 249b
332b
∼470c
GK13 ∼520c 101
aThe ligand concentration was 1.5 × 10−3 M. Ligand to metal ratio
was 1:0.9. bN− → Cu(III) CT bands; cCu(II) d−d transitions.
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Figure 3. Cu K-edge EXAFS signals (left panel) and Fourier transforms (right panel) of Cu(III) (red line) and Cu(II) (blue line) peptide samples
(○, EXAFS;  theoretical; · · · residual).
Figure 4. Different contributions to the EXAFS signals of Cu(III) (left panel) and Cu(II) (right panel) containing peptide samples.
Figure 5. Left frame: Theoretical XANES spectra (without broadening) of DK13/Cu(III) and GK13/Cu(II). Right frame: Theoretical vs
experimental XANES fit (after broadening) of DK13 (red) and GK13 (black) copper complexes, obtained by refining structural and nonstructural
parameters.
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■ CONCLUSIONS
Comparison of XANES pre-edge peak features with those of
Cu model compounds allowed to determine the Cu oxidation
state in the three peptides: Cu is purely divalent in GK13,
trivalent in DK13, at least in the detection limits of the method,
whereas LK13 forms complexes both with Cu(II) and Cu(III)
ions. Spectroscopic UV−vis data confirm these results except
for peptide 1 where a small amount of Cu(II) could be still
identified. Notably, also edge energies and the Cu−N distances
derived independently by GNXAS (1.79 Å and 1.90 Å in the
EXAFS range) and MXAN (1.80 Å and 1.91 Å in the XANES
range) for DK13 and GK13 respectively are consistent with the
XANES determined Cu oxidation states. Finally, the good
agreement between structural data of the Cu(III) local
environment determined independently by EXAFS and
XANES testifies the reliability of the determined Cu location
and coordination geometry.
Preliminary theoretical XANES spectra (data not shown)
calculated using the MXAN code in a different way (i.e., by
fixing the optimized distances and releasing angular parame-
ters) suggest that the CuN4 unit is not perfectly planar but form
a distorted pyramid. The Cu(III) is bonded to the four amidic
nitrogens, giving rise a quasi-planar square structure. In fact the
deviation from the planar coordination is very small (the angle
N−Cu−N of two opposite nitrogens is about 170°) and the
pyramidal structure is near to be flat. The proposed structures
for DK13/Cu(III) and GK13/Cu(II) are depicted in Figures 6
and 7.
The absence in GK13 of the Cu(III) coordinated species
reported in Figure 6 for DK13, although peptides (1) and (3)
have the same size of the peptide ring, might be tentatively
explained by the control of the backbone-hanging imidazole
side chains coming from D- and L-histidines, which are not
present in compound (3). Surprisingly, it also appears that the
chirality of His residues may play a role in the Cu(II) →
Cu(III) oxidation pattern as peptide (2)/Cu(II) complex, that
contains two L-histidines, was oxidized only in part. The
addition of imidazole itself into a solution of GK13/Cu(II) did
not produce anyway the formation of the Cu(III) ions, but the
spectra remain substantially unchanged respect to those
collected for GK13/Cu(II) mixture. The mechanism by
which the histidine residues act in creating the suitable cradle
for dioxygen Cu(II)→ Cu(III) formation is not clarified at this
stage. A pH dependent EXAFS study in aqueous solution will
be necessary for revealing in detail the role of the D- and L-
histidine in cyclopeptide (1) and (2) copper complexing.
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Table 2. Essential Parameters of the XANES Fit (Errors in Brackets)
sample sq. residuala overlap factor (%) V0imp (eV) ⟨CuN⟩ (Å)
b ⟨Cu−C⟩ (Å)b,c
DK13 1.9447 4.95 (0.09) −11.98 (2.0) 1.80 (0.04) 2.84 (0.08)
1.78 (0.02) 2.89 (0.02)
GK13 1.4712 1.34 (0.02) −8.92 (2.0) 1.91 (0.02) 2.94 (0.02)
1.92 (0.02) 2.97 (0.02)
aThe definition of the square residual is given in ref 15. bFor comparison purpose, also the EXAFS derived values are given in italics. cThis value
represent an average of the eight shortest Cu−C distances.
Figure 6. Proposed structure for DK13/Cu(III) complex on the basis
of XANES data.
Figure 7. Proposed structure for GK13/Cu(II) complex on the basis
of UV−vis data.
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